Corporate Profile

Corporate Profile

Teleflex is a global provider of medical technology products that enhance clinical benefits, improve patient and provider safety and reduce total procedural costs. To achieve this mission, Teleflex is committed to the following: investing in technology and developing our pipeline; leveraging and building our core franchises and distribution channels; attracting, developing and retaining talented employees around the world; and continuing to build financial strength by expanding our margins and maintaining strong cash flow all in an effort to successfully grow our reputation as a solid investment and a profitable, strong employer. We primarily design, develop, manufacture and supply single-use medical devices used by hospitals and healthcare providers for common diagnostic and therapeutic procedures in critical care and surgical applications. We sell our products to hospitals and healthcare providers worldwide through a combination of our direct sales force and distributors. Our products are used in a wide variety of markets and are not dependent upon any one end-market or procedure.

We are focused on achieving consistent , sustainable and profitable growth by increasing our market share and improving operating efficiencies through:

  • • the development of new products and product line extensions;

  • • the investment in new technologies and broadening their applications;

  • • the expansion of the use of existing products in existing markets, as well as in new geographic markets;

  • • leveraging our direct sales force and distribution network with new products, manufacturing and distribution facility rationalization and achieving economies of scale as we continue to expand; and

  • • the potential broadening of our product portfolio through select acquisitions, licensing arrangements and partnerships that enhance, extend or expedite our development initiatives or our ability to increase our market share.
 
Recent NewsMore »
08/03/17
Teleflex Announces Quarterly Dividend
WAYNE, Pa.--(BUSINESS WIRE)--Aug. 3, 2017-- Teleflex Incorporated (NYSE: TFX) announced today that its Board of Directors declared a quarterly cash dividend of thirty-four cents ($0.34) per share of common stock. The dividend is payable September 15, 2017 to shareholders of record at the close of business on August 15, 2017. Additional information about Teleflex can be obtained from the company’s website at www.teleflex.com. About Teleflex... 
08/03/17
Teleflex Reports Second Quarter 2017 Results
Second Quarter Revenues of $528.6 million, up 11.6% Versus Prior Year Period; up 12.9% on Constant Currency Basis Second Quarter GAAP Diluted EPS of $1.67, up 33.6% Over Prior Year Period Second Quarter Adjusted Diluted EPS of $2.04, up 7.9% Versus Prior Year Period Raised 2017 Guidance Range for GAAP Revenue Growth from a Range of 10.0% to 11.5% to a Range of 11.5% to 13.0% Reaffirmed 2017 Guidance Range for... 
07/24/17
Arrow® Seldinger Arterial Catheterization Device Receives FDA Market Clearance
Designed for Risk Reduction, Optimal Performance, and Patient Safety WAYNE, Pa.--(BUSINESS WIRE)--Jul. 24, 2017-- Teleflex Incorporated (NYSE: TFX), a leading global provider of medical technologies for critical care and surgery, has announced today that its Arrow® Seldinger Arterial Catheterization Device received market clearance from the U.S. Food and Drug Administration (FDA). The new Seldinger Arterial Catheterization Device is indicated... 
07/20/17
Teleflex Announces Second Quarter 2017 Earnings Conference Call Information
Live Webcast is scheduled at 8:00 a.m. (ET) on Thursday, August 3, 2017 WAYNE, Pa.--(BUSINESS WIRE)--Jul. 20, 2017-- Teleflex Incorporated (NYSE: TFX) announced today that financial results for the second quarter 2017 will be released before market open on Thursday, August 3, 2017. An investor conference call will be held at 8:00 a.m. (ET) on Thursday, August 3, 2017. The call can be accessed through a live audio webcast on the company’s websi... 
 
Upcoming EventsMore »
There are currently no events scheduled.
 
Data provided by Nasdaq. Minimum 15 minutes delayed.


Print Page Print Page | RSS Feeds RSS Feeds | E-mail Alerts E-mail Alerts | IR Contacts IR Contacts | Financial Tear Sheet Financial Tear Sheet